A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBD09

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a randomized, double-blind, placebo-controlled, multiple dose trial of TBD09, administered to healthy adult participants to assess safety, tolerability, and pharmacokinetics up to 84 days of fixed daily dosing of TBD09. The trial will be conducted with two cohorts, with participants enrolled in parallel and randomized to receive either TBD09 or placebo.
Epistemonikos ID: c974bc21056b731c78a0cae89538b680c3a4757a
First added on: Aug 01, 2025